BioSpace News Archive

Deals

CEN Biotech Inc. announces a Merger Agreement with CSOC

On May 15, 2019, CEN Biotech, Inc. entered into a Non-Binding Term Sheet with Caduceus Software Systems Corp., a Wyoming corporation, which was reviewed and approved by the Board of Directors of CEN on May 15, 2019.

May 16, 2019
·
3 min read
Deals

Egalet Reports First Quarter 2019 Financial Results and Plan to Change Company Name to Zyla Life Sciences

Egalet Corporation reported financial results for the first quarter ended March 31, 2019 and announced it will change its name to Zyla Life Sciences in the coming weeks.

May 16, 2019
·
9 min read
Business

Inovio and QIAGEN Establish Collaboration to Develop Diagnostic Test for VGX-3100, Inovio’s Novel Immunotherapy Targeting Advanced Cervical Pre-Cancer

Liquid biopsy-based Precision Medicine test to guide patient selection for Inovio’s VGX-3100

May 16, 2019
·
9 min read
Business

QIAGEN and Inovio Collaborate to Develop Companion Diagnostic for Novel Immunotherapy Targeting Precancerous Cervical Lesions

Liquid biopsy-based Precision Medicine test to guide patient selection for Inovio’s VGX-3100

May 16, 2019
·
2 min read
EKF’s DiaSpect Tm hemoglobin analyzer supports anemia study in resource limited West Africa

EKF Diagnostics, the global in vitro diagnostics company, announces the highly successful use of its FDA cleared DiaSpect Tm (sold as Consult Hb in the USA) point-of-care hemoglobin analyzer to study iron-deficient anemia in a remote region of Ghana, West Africa.

May 16, 2019
·
5 min read
Drug Development

Constellation Pharmaceuticals Provides Interim Update of Data for CPI-0610 in ASCO and EHA Abstracts

Constellation Pharmaceuticals, Inc. (Nasdaq: CNST) today announced that two abstracts relating to the MANIFEST clinical trial of CPI-0610 for myelofibrosis – one in association with the American Society for Clinical Oncology (ASCO) annual meeting and the other in association with the European Hematology Association (EHA) annual meeting – published online.

May 16, 2019
·
8 min read
BioMidwest

Lilly to Participate in UBS Global Healthcare Conference

Christi Shaw, president of Lilly Bio-Medicines, will participate in a fireside chat at 9:30 a.m., Eastern Time.

May 16, 2019
·
1 min read
Drug Development

Sareum notes that Sierra Oncology has provided an update on its clinical data presentations at ASCO 2019 with SRA737 (a Chk1 inhibitor) in subjects with advanced cancer

Sareum Holdings plc (AIM: SAR), the specialist small molecule drug development business, notes that Sierra Oncology (the licence holder for Chk1 inhibitor SRA737) has provided further information relating to presentations of preliminary clinical data from its Phase 1/2 SRA737 monotherapy study

May 16, 2019
·
5 min read
World’s first ‘Darwinian’ cancer drug programme aims to deliver step change in cancer treatment

The world’s first ‘Darwinian’ drug discovery programme specially designed to tackle cancer’s lethal ability to evolve resistance to treatment is to be launched in a state-of-the-art new building in London.

May 16, 2019
·
9 min read
Business

Regional Health Properties Receives Audit Opinion with Going Concern Explanation and Reports Fourth Quarter and Full-Year 2018 Financial Results

The audited financial statements for the year ended December 31, 2018 included in the Annual Report on Form 10-K contained an audit opinion from its independent registered public accounting firm

May 16, 2019
·
14 min read